Many studies have demonstrated NP systems conjugated with hyaluronic acid, a CD44 native ligand, as a promising approach to the targeted delivery of therapeutic agents to cancer stem cells, which are often responsible for MDR [164,166]. Here, CD44 is linked to cancer.